Iopidine

Apraclonidine, the active ingredient in Iopidine, is a alpha-2 adrenergic agonist presented as a ophthalmic solution for ocular (topical) use. It reduces intra‑ocular pressure in ocular hypertension and open‑angle glaucoma. GNH USA supplies Iopidine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iopidine (apraclonidine) is used in the management of ocular hypertension and glaucoma, conditions characterized by elevated intra‑ocular pressure.

- Ocular hypertension: reduction of intra‑ocular pressure to prevent progression to glaucoma. - Open‑angle glaucoma: lowering intra‑ocular pressure to slow optic nerve damage. - Post‑operative ocular pressure spikes: control of transient pressure elevations after eye surgery.

Adverse ocular and systemic reactions have been reported with apraclonidine ophthalmic solution.

Common Side Effects: - Burning or stinging sensation: transient discomfort upon instillation. - Redness of the eye: mild conjunctival hyperemia. - Blurred vision: temporary visual disturbance. - Dry eye: mild decrease in tear production.

Serious or Rare Side Effects: - Allergic reaction: swelling, itching, or rash requiring medical attention. - Severe ocular inflammation: uveitis or keratitis. - Systemic hypotension: marked drop in blood pressure, especially in sensitive patients.

When prescribing apraclonidine, clinicians should consider several safety and handling precautions. - Contraindication: known hypersensitivity to apraclonidine or any component of the formulation. - Caution: patients with cardiovascular disease or low blood pressure should be monitored. - Pregnancy: safety not established; use only if potential benefit justifies risk. - Breastfeeding: unknown excretion; weigh benefits against potential infant exposure. - Interaction caution: avoid concurrent use with other ocular alpha‑agonists without supervision. - Store at room temperature: keep in original container, protect from light and moisture.

Apraclonidine may interact with other ophthalmic agents and systemic medications.

Major Interactions (Avoid): - Other alpha‑adrenergic agonists: additive ocular hypotensive effect may cause excessive pressure reduction. - Systemic antihypertensives: concurrent use can potentiate hypotension.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: combined effect on aqueous humor dynamics may require IOP monitoring. - MAO inhibitors: potential for enhanced central nervous system effects. - Topical anesthetics: may increase ocular irritation when used together.